APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatology Drugs for Pets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dermatology Drugs for Pets Industry Growth and Trends Forecast to 2032

2 January 202692 pages

Choose your research edition.

Industry ResearchDermatology Drugs for Pets Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatology Drugs for Pets Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Dermatology Drugs for Pets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatology Drugs for Pets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatology Drugs for Pets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Dermatology Drugs for Pets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dermatology Drugs for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dermatology Drugs for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dermatology Drugs for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dermatology Drugs for Pets include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Elanco, IDEXX Laboratories, Merial, Vetoquinol S.A.panies, Virbac S.A. and Zoetis Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dermatology Drugs for Pets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dermatology Drugs for Pets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dermatology Drugs for Pets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dermatology Drugs for Pets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dermatology Drugs for Pets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dermatology Drugs for Pets Market by Company

Bayer Animal Health

Boehringer Ingelheim Vetmedica

Ceva Sante Animale

Elanco

IDEXX Laboratories

Merial

Vetoquinol S.A.panies

Virbac S.A.

Zoetis Inc.

Dermatology Drugs for Pets Segment by Type

Antibiotics

Antifungal Drugs

Others

Dermatology Drugs for Pets Segment by Application

Pets Clinics

Pets Hospitals

Others

Dermatology Drugs for Pets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drugs for Pets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drugs for Pets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drugs for Pets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatology Drugs for Pets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dermatology Drugs for Pets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antibiotics Table 2. Major Company of Antifungal Drugs Table 3. Major Company of Others Table 4. Global Dermatology Drugs for Pets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dermatology Drugs for Pets Sales by Type (2021-2026) & (K Units) Table 6. Global Dermatology Drugs for Pets Sales Market Share in Volume by Type (2021-2026) Table 7. Global Dermatology Drugs for Pets Sales by Type (2021-2026) & (US$ Million) Table 8. Global Dermatology Drugs for Pets Sales Market Share in Value by Type (2021-2026) Table 9. Global Dermatology Drugs for Pets Price by Type (2021-2026) & (US$/Unit) Table 10. Global Dermatology Drugs for Pets Sales by Type (2027-2032) & (K Units) Table 11. Global Dermatology Drugs for Pets Sales Market Share in Volume by Type (2027-2032) Table 12. Global Dermatology Drugs for Pets Sales by Type (2027-2032) & (US$ Million) Table 13. Global Dermatology Drugs for Pets Sales Market Share in Value by Type (2027-2032) Table 14. Global Dermatology Drugs for Pets Price by Type (2027-2032) & (US$/Unit) Table 15. North America Dermatology Drugs for Pets Sales by Type (2021-2026) & (K Units) Table 16. North America Dermatology Drugs for Pets Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Dermatology Drugs for Pets Sales by Type (2021-2026) & (K Units) Table 18. Europe Dermatology Drugs for Pets Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Dermatology Drugs for Pets Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Dermatology Drugs for Pets Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Dermatology Drugs for Pets Sales by Type (2021-2026) & (K Units) Table 22. Latin America Dermatology Drugs for Pets Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Dermatology Drugs for Pets Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Dermatology Drugs for Pets Sales by Type (2021-2026) & (US$ Million) Table 25. Dermatology Drugs for Pets Industry Trends Table 26. Dermatology Drugs for Pets Industry Drivers Table 27. Dermatology Drugs for Pets Industry Opportunities and Challenges Table 28. Dermatology Drugs for Pets Industry Restraints Table 29. Global Dermatology Drugs for Pets Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Dermatology Drugs for Pets Revenue Market Share by Company (2021-2026) Table 31. Global Dermatology Drugs for Pets Sales by Company (2021-2026) & (K Units) Table 32. Global Dermatology Drugs for Pets Sales Share by Company (2021-2026) Table 33. Global Dermatology Drugs for Pets Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Dermatology Drugs for Pets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Dermatology Drugs for Pets Major Company Production Sites and Headquarters Table 36. Global Dermatology Drugs for Pets Company, Product Type & Application Table 37. Global Dermatology Drugs for Pets Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Dermatology Drugs for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Dermatology Drugs for Pets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Dermatology Drugs for Pets Sales by Region (2021-2026) & (K Units) Table 42. Global Dermatology Drugs for Pets Sales Market Share in Volume by Region (2021-2026) Table 43. Global Dermatology Drugs for Pets Sales by Region (2021-2026) & (US$ Million) Table 44. Global Dermatology Drugs for Pets Sales Market Share in Value by Region (2021-2026) Table 45. Global Dermatology Drugs for Pets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Dermatology Drugs for Pets Sales by Region (2027-2032) & (K Units) Table 47. Global Dermatology Drugs for Pets Sales Market Share in Volume by Region (2027-2032) Table 48. Global Dermatology Drugs for Pets Sales by Region (2027-2032) & (US$ Million) Table 49. Global Dermatology Drugs for Pets Sales Market Share in Value by Region (2027-2032) Table 50. Global Dermatology Drugs for Pets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Dermatology Drugs for Pets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Dermatology Drugs for Pets Sales by Application (2021-2026) & (K Units) Table 53. Global Dermatology Drugs for Pets Sales Market Share in Volume by Application (2021-2026) Table 54. Global Dermatology Drugs for Pets Sales by Application (2021-2026) & (US$ Million) Table 55. Global Dermatology Drugs for Pets Sales Market Share in Value by Application (2021-2026) Table 56. Global Dermatology Drugs for Pets Price by Application (2021-2026) & (US$/Unit) Table 57. Global Dermatology Drugs for Pets Sales by Application (2027-2032) & (K Units) Table 58. Global Dermatology Drugs for Pets Sales Market Share in Volume by Application (2027-2032) Table 59. Global Dermatology Drugs for Pets Sales by Application (2027-2032) & (US$ Million) Table 60. Global Dermatology Drugs for Pets Sales Market Share in Value by Application (2027-2032) Table 61. Global Dermatology Drugs for Pets Price by Application (2027-2032) & (US$/Unit) Table 62. North America Dermatology Drugs for Pets Sales by Application (2021-2026) & (K Units) Table 63. North America Dermatology Drugs for Pets Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Dermatology Drugs for Pets Sales by Application (2021-2026) & (K Units) Table 65. Europe Dermatology Drugs for Pets Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Dermatology Drugs for Pets Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Dermatology Drugs for Pets Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Dermatology Drugs for Pets Sales by Application (2021-2026) & (K Units) Table 69. Latin America Dermatology Drugs for Pets Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Dermatology Drugs for Pets Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Dermatology Drugs for Pets Sales by Application (2021-2026) & (US$ Million) Table 72. Bayer Animal Health Company Information Table 73. Bayer Animal Health Business Overview Table 74. Bayer Animal Health Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bayer Animal Health Dermatology Drugs for Pets Product Portfolio Table 76. Bayer Animal Health Recent Development Table 77. Boehringer Ingelheim Vetmedica Company Information Table 78. Boehringer Ingelheim Vetmedica Business Overview Table 79. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Product Portfolio Table 81. Boehringer Ingelheim Vetmedica Recent Development Table 82. Ceva Sante Animale Company Information Table 83. Ceva Sante Animale Business Overview Table 84. Ceva Sante Animale Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Ceva Sante Animale Dermatology Drugs for Pets Product Portfolio Table 86. Ceva Sante Animale Recent Development Table 87. Elanco Company Information Table 88. Elanco Business Overview Table 89. Elanco Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Elanco Dermatology Drugs for Pets Product Portfolio Table 91. Elanco Recent Development Table 92. IDEXX Laboratories Company Information Table 93. IDEXX Laboratories Business Overview Table 94. IDEXX Laboratories Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. IDEXX Laboratories Dermatology Drugs for Pets Product Portfolio Table 96. IDEXX Laboratories Recent Development Table 97. Merial Company Information Table 98. Merial Business Overview Table 99. Merial Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Merial Dermatology Drugs for Pets Product Portfolio Table 101. Merial Recent Development Table 102. Vetoquinol S.A.panies Company Information Table 103. Vetoquinol S.A.panies Business Overview Table 104. Vetoquinol S.A.panies Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Vetoquinol S.A.panies Dermatology Drugs for Pets Product Portfolio Table 106. Vetoquinol S.A.panies Recent Development Table 107. Virbac S.A. Company Information Table 108. Virbac S.A. Business Overview Table 109. Virbac S.A. Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Virbac S.A. Dermatology Drugs for Pets Product Portfolio Table 111. Virbac S.A. Recent Development Table 112. Zoetis Inc. Company Information Table 113. Zoetis Inc. Business Overview Table 114. Zoetis Inc. Dermatology Drugs for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Zoetis Inc. Dermatology Drugs for Pets Product Portfolio Table 116. Zoetis Inc. Recent Development Table 117. North America Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Dermatology Drugs for Pets Sales by Country (2021-2026) & (K Units) Table 119. North America Dermatology Drugs for Pets Sales Market Share by Country (2021-2026) Table 120. North America Dermatology Drugs for Pets Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Dermatology Drugs for Pets Sales Market Share Forecast by Country (2027-2032) Table 122. North America Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Dermatology Drugs for Pets Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Dermatology Drugs for Pets Market Share by Country (2021-2026) Table 125. North America Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Dermatology Drugs for Pets Market Share Forecast by Country (2027-2032) Table 127. Europe Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Dermatology Drugs for Pets Sales by Country (2021-2026) & (K Units) Table 129. Europe Dermatology Drugs for Pets Sales Market Share by Country (2021-2026) Table 130. Europe Dermatology Drugs for Pets Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Dermatology Drugs for Pets Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Dermatology Drugs for Pets Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Dermatology Drugs for Pets Market Share by Country (2021-2026) Table 135. Europe Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Dermatology Drugs for Pets Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Dermatology Drugs for Pets Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Dermatology Drugs for Pets Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Dermatology Drugs for Pets Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Dermatology Drugs for Pets Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Dermatology Drugs for Pets Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Dermatology Drugs for Pets Market Share by Country (2021-2026) Table 145. Asia-Pacific Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Dermatology Drugs for Pets Market Share Forecast by Country (2027-2032) Table 147. Latin America Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Dermatology Drugs for Pets Sales by Country (2021-2026) & (K Units) Table 149. Latin America Dermatology Drugs for Pets Sales Market Share by Country (2021-2026) Table 150. Latin America Dermatology Drugs for Pets Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Dermatology Drugs for Pets Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Dermatology Drugs for Pets Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Dermatology Drugs for Pets Market Share by Country (2021-2026) Table 155. Latin America Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Dermatology Drugs for Pets Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Dermatology Drugs for Pets Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Dermatology Drugs for Pets Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Dermatology Drugs for Pets Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Dermatology Drugs for Pets Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Dermatology Drugs for Pets Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Dermatology Drugs for Pets Market Share by Country (2021-2026) Table 165. Middle East and Africa Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Dermatology Drugs for Pets Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Dermatology Drugs for Pets Distributors List Table 170. Dermatology Drugs for Pets Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Dermatology Drugs for Pets Image Figure 2. Global Dermatology Drugs for Pets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatology Drugs for Pets Market Size (2021-2032) & (US$ Million) Figure 4. Global Dermatology Drugs for Pets Sales (2021-2032) & (K Units) Figure 5. Antibiotics Image Figure 6. Global Antibiotics Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antifungal Drugs Image Figure 8. Global Antifungal Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Dermatology Drugs for Pets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Dermatology Drugs for Pets Market Share by Type 2025 VS 2032 Figure 13. North America Dermatology Drugs for Pets Sales Market Share in Volume by Type in 2025 Figure 14. North America Dermatology Drugs for Pets Sales Market Share in Value by Type in 2025 Figure 15. Europe Dermatology Drugs for Pets Sales Market Share in Volume by Type in 2025 Figure 16. Europe Dermatology Drugs for Pets Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Dermatology Drugs for Pets Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Dermatology Drugs for Pets Sales Market Share in Value by Type in 2025 Figure 19. Latin America Dermatology Drugs for Pets Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Dermatology Drugs for Pets Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Dermatology Drugs for Pets Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Dermatology Drugs for Pets Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Dermatology Drugs for Pets Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Pets Clinics Image Figure 26. Global Pets Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pets Hospitals Image Figure 28. Global Pets Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Dermatology Drugs for Pets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Dermatology Drugs for Pets Market Share by Application 2025 VS 2032 Figure 33. North America Dermatology Drugs for Pets Sales Market Share in Volume by Application in 2025 Figure 34. North America Dermatology Drugs for Pets Sales Market Share in Value by Application in 2025 Figure 35. Europe Dermatology Drugs for Pets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Dermatology Drugs for Pets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Dermatology Drugs for Pets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Dermatology Drugs for Pets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Dermatology Drugs for Pets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Dermatology Drugs for Pets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Dermatology Drugs for Pets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Dermatology Drugs for Pets Sales Market Share in Value by Application in 2025 Figure 43. North America Dermatology Drugs for Pets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Dermatology Drugs for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Dermatology Drugs for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Dermatology Drugs for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dermatology Drugs for Pets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Dermatology Drugs for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Dermatology Drugs for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Dermatology Drugs for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dermatology Drugs for Pets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Dermatology Drugs for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Dermatology Drugs for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Dermatology Drugs for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dermatology Drugs for Pets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Dermatology Drugs for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Dermatology Drugs for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Dermatology Drugs for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dermatology Drugs for Pets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Dermatology Drugs for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Dermatology Drugs for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Dermatology Drugs for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Dermatology Drugs for Pets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Dermatology Drugs for Pets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Antifungal Drugs
  • Others
Applications
  • Pets Clinics
  • Pets Hospitals
  • Others
Companies covered
  • Bayer Animal Health
  • Boehringer Ingelheim Vetmedica
  • Ceva Sante Animale
  • Elanco
  • IDEXX Laboratories
  • Merial
  • Vetoquinol S.A.panies
  • Virbac S.A.
  • Zoetis Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dermatology Drugs for Pets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dermatology Drugs for Pets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dermatology Drugs for Pets Market by Type
  6. 1.3.1 Antibiotics
  7. 1.3.2 Antifungal Drugs
  8. 1.3.3 Others
  9. 1.4 Global Dermatology Drugs for Pets Market Size by Type
  10. 1.4.1 Global Dermatology Drugs for Pets Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Dermatology Drugs for Pets Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Dermatology Drugs for Pets Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Dermatology Drugs for Pets Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Dermatology Drugs for Pets Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Dermatology Drugs for Pets Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Dermatology Drugs for Pets Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Dermatology Drugs for Pets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dermatology Drugs for Pets Industry Trends
  2. 2.2 Dermatology Drugs for Pets Industry Drivers
  3. 2.3 Dermatology Drugs for Pets Industry Opportunities and Challenges
  4. 2.4 Dermatology Drugs for Pets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dermatology Drugs for Pets Revenue (2021-2026)
  2. 3.2 Global Top Players by Dermatology Drugs for Pets Sales (2021-2026)
  3. 3.3 Global Top Players by Dermatology Drugs for Pets Price (2021-2026)
  4. 3.4 Global Dermatology Drugs for Pets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dermatology Drugs for Pets Major Company Production Sites & Headquarters
  6. 3.6 Global Dermatology Drugs for Pets Company, Product Type & Application
  7. 3.7 Global Dermatology Drugs for Pets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dermatology Drugs for Pets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dermatology Drugs for Pets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dermatology Drugs for Pets Tier 1, Tier 2, and Tier 3
4 Dermatology Drugs for Pets Regional Status and Outlook
  1. 4.1 Global Dermatology Drugs for Pets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dermatology Drugs for Pets Historic Market Size by Region
  3. 4.2.1 Global Dermatology Drugs for Pets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dermatology Drugs for Pets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dermatology Drugs for Pets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dermatology Drugs for Pets Forecasted Market Size by Region
  7. 4.3.1 Global Dermatology Drugs for Pets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dermatology Drugs for Pets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dermatology Drugs for Pets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dermatology Drugs for Pets by Application
  1. 5.1 Dermatology Drugs for Pets Market by Application
  2. 5.1.1 Pets Clinics
  3. 5.1.2 Pets Hospitals
  4. 5.1.3 Others
  5. 5.2 Global Dermatology Drugs for Pets Market Size by Application
  6. 5.2.1 Global Dermatology Drugs for Pets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dermatology Drugs for Pets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dermatology Drugs for Pets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dermatology Drugs for Pets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dermatology Drugs for Pets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dermatology Drugs for Pets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dermatology Drugs for Pets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dermatology Drugs for Pets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer Animal Health
  2. 6.1.1 Bayer Animal Health Company Information
  3. 6.1.2 Bayer Animal Health Business Overview
  4. 6.1.3 Bayer Animal Health Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer Animal Health Dermatology Drugs for Pets Product Portfolio
  6. 6.1.5 Bayer Animal Health Recent Developments
  7. 6.2 Boehringer Ingelheim Vetmedica
  8. 6.2.1 Boehringer Ingelheim Vetmedica Company Information
  9. 6.2.2 Boehringer Ingelheim Vetmedica Business Overview
  10. 6.2.3 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Vetmedica Recent Developments
  13. 6.3 Ceva Sante Animale
  14. 6.3.1 Ceva Sante Animale Company Information
  15. 6.3.2 Ceva Sante Animale Business Overview
  16. 6.3.3 Ceva Sante Animale Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ceva Sante Animale Dermatology Drugs for Pets Product Portfolio
  18. 6.3.5 Ceva Sante Animale Recent Developments
  19. 6.4 Elanco
  20. 6.4.1 Elanco Company Information
  21. 6.4.2 Elanco Business Overview
  22. 6.4.3 Elanco Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Elanco Dermatology Drugs for Pets Product Portfolio
  24. 6.4.5 Elanco Recent Developments
  25. 6.5 IDEXX Laboratories
  26. 6.5.1 IDEXX Laboratories Company Information
  27. 6.5.2 IDEXX Laboratories Business Overview
  28. 6.5.3 IDEXX Laboratories Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 IDEXX Laboratories Dermatology Drugs for Pets Product Portfolio
  30. 6.5.5 IDEXX Laboratories Recent Developments
  31. 6.6 Merial
  32. 6.6.1 Merial Company Information
  33. 6.6.2 Merial Business Overview
  34. 6.6.3 Merial Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merial Dermatology Drugs for Pets Product Portfolio
  36. 6.6.5 Merial Recent Developments
  37. 6.7 Vetoquinol S.A.panies
  38. 6.7.1 Vetoquinol S.A.panies Company Information
  39. 6.7.2 Vetoquinol S.A.panies Business Overview
  40. 6.7.3 Vetoquinol S.A.panies Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vetoquinol S.A.panies Dermatology Drugs for Pets Product Portfolio
  42. 6.7.5 Vetoquinol S.A.panies Recent Developments
  43. 6.8 Virbac S.A.
  44. 6.8.1 Virbac S.A. Company Information
  45. 6.8.2 Virbac S.A. Business Overview
  46. 6.8.3 Virbac S.A. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Virbac S.A. Dermatology Drugs for Pets Product Portfolio
  48. 6.8.5 Virbac S.A. Recent Developments
  49. 6.9 Zoetis Inc.
  50. 6.9.1 Zoetis Inc. Company Information
  51. 6.9.2 Zoetis Inc. Business Overview
  52. 6.9.3 Zoetis Inc. Dermatology Drugs for Pets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zoetis Inc. Dermatology Drugs for Pets Product Portfolio
  54. 6.9.5 Zoetis Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Dermatology Drugs for Pets Sales by Country
  2. 7.1.1 North America Dermatology Drugs for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dermatology Drugs for Pets Sales by Country (2021-2026)
  4. 7.1.3 North America Dermatology Drugs for Pets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dermatology Drugs for Pets Market Size by Country
  6. 7.2.1 North America Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dermatology Drugs for Pets Market Size by Country (2021-2026)
  8. 7.2.3 North America Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dermatology Drugs for Pets Sales by Country
  2. 8.1.1 Europe Dermatology Drugs for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dermatology Drugs for Pets Sales by Country (2021-2026)
  4. 8.1.3 Europe Dermatology Drugs for Pets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dermatology Drugs for Pets Market Size by Country
  6. 8.2.1 Europe Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dermatology Drugs for Pets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dermatology Drugs for Pets Sales by Country
  2. 9.1.1 Asia-Pacific Dermatology Drugs for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dermatology Drugs for Pets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dermatology Drugs for Pets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dermatology Drugs for Pets Market Size by Country
  6. 9.2.1 Asia-Pacific Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dermatology Drugs for Pets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dermatology Drugs for Pets Sales by Country
  2. 10.1.1 South America Dermatology Drugs for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dermatology Drugs for Pets Sales by Country (2021-2026)
  4. 10.1.3 South America Dermatology Drugs for Pets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dermatology Drugs for Pets Market Size by Country
  6. 10.2.1 South America Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dermatology Drugs for Pets Market Size by Country (2021-2026)
  8. 10.2.3 South America Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dermatology Drugs for Pets Sales by Country
  2. 11.1.1 Middle East and Africa Dermatology Drugs for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dermatology Drugs for Pets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dermatology Drugs for Pets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dermatology Drugs for Pets Market Size by Country
  6. 11.2.1 Middle East and Africa Dermatology Drugs for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dermatology Drugs for Pets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dermatology Drugs for Pets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dermatology Drugs for Pets Value Chain Analysis
  2. 12.1.1 Dermatology Drugs for Pets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dermatology Drugs for Pets Production Mode & Process
  7. 12.2 Dermatology Drugs for Pets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dermatology Drugs for Pets Distributors
  10. 12.2.3 Dermatology Drugs for Pets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst